Micromet Inc.

NASDAQ:MITI ISIN:US59509C1053

 
 

News

Micromet Inc. (NASDAQ:MITI) Data Published In Nature Cell Biology Reveal Novel Function Of Drug Target EpCAM In Cancer Cell Signalling

🕔1/13/2009 11:01:00 PM 2070

Micromet Inc. (NASDAQ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (NASDAQ:MITI) Micromet Key Events For 2009

🕔1/5/2009 11:01:00 PM 1527

Micromet Inc. (NASDAQ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet Presents Updated Data On The Phase 1 Trial Studying Blinatumomab (MT103/MEDI-538) In Patients With Advanced Non-Hodgkin's Lymphoma

🕔12/9/2008 11:01:00 PM 1507

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Data Presented At ASH Annual Meeting Indicates The Potential Of T-cell Engaging BiTE Antibody Blinatumomab As A Consolidation Treatment For Aggressive Leukemias

🕔12/8/2008 11:01:00 PM 1266

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet, Inc. To Host Webcast And Conference Call To Discuss Blinatumomab Data Presented At American Society Of Hematology Annual Meeting

🕔12/3/2008 11:03:00 PM 1272

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet Expands Committed Equity Financing Facility To $75 Million

🕔12/2/2008 11:03:00 PM 1355

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet To Present At The Piper Jaffray 20th Annual Health Care Conference

🕔11/27/2008 8:05:00 AM 1204

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet Added To NASDAQ Biotechnology Index

🕔11/27/2008 8:03:00 AM 965

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet To Present Interim Data From Two Studies For T Cell Engaging BiTE Antibody Blinatumomab At American Society Of Hematolgy Annual Meeting

🕔11/13/2008 10:03:00 PM 949

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸

Micromet Inc. (OJ:MITI) Micromet Presents Data At The 23rd Annual Meeting Of The International Society For Biological Therapy Of Cancer On The Activity Of Human Antibody Adecatumumab Against KRAS-mutated Colon Cancer Cells

🕔11/4/2008 10:03:00 PM 869

Micromet Inc. (OJ:MITI) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel▸
###

3,962 COMPANY PROFILE VIEWS

  • Diese Seite wurde besucht: (letzten 7 Tagen: 12) (letzten 30 Tagen: 54) (seit Veröffentlichung: 3962) 

Company Data